Lacharon, Jennylen .
HRN: 26-32-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2025
CEFUROXIME 1.5GM (VIAL)
01/06/2025
01/12/2025
IVLD
1.5grams
Q8
Wbc- 31.6 (cause To Be Determined)
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes